Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer

NCT04627948 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04627948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04627948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
July 1, 2019
Completion date
July 1, 2024
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer